Sunshine Biopharma, Inc. (SBFMW)

CA — Healthcare Sector
Peers: SBFM  ISPOW  BFRIW  MDVL  NRSN 

Automate Your Wheel Strategy on SBFMW

With Tiblio's Option Bot, you can configure your own wheel strategy including SBFMW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol SBFMW
  • Rev/Share 49.6962
  • Book/Share 33.4888
  • PB 0.043
  • Debt/Equity 0.0405
  • CurrentRatio 4.1119
  • ROIC -0.2273

 

  • MktCap 6560568.0
  • FreeCF/Share -21.0325
  • PFCF -0.4445
  • PE -0.1968
  • Debt/Assets 0.0312
  • DivYield 0
  • ROE -0.212

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Sunshine Biopharma, Inc. (SBFMW)

  • IPO Date 2022-02-15
  • Website https://www.sunshinebiopharma.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Dr. Steve N. Slilaty Ph.D.
  • Employees 52
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.